Wednesday, July 8, 2026

pharma · Dyslipidemia at High to Very High Cardiovascular Risk · Suspected or confirmed Gram negative infections

Menarini Asia-Pacific

News and analysis for Menarini Asia-Pacific on NovaPharmaNews — regulatory, clinical, and market coverage.

Singapore, SG HQ
720 Employees
TGA registrant Type
Company details
Status
Public
HQ
Singapore, SG
Employees
720
Programs
2
Drugs
15
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Menarini Asia-Pacific — regulatory, clinical, and market coverage.

News and analysis for Menarini Asia-Pacific on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Menarini Asia-Pacific yet.

Back to company overview →